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ABSTRACT
THE MECHANISM OF ASSEMBLY OF THE G-PROTEIN βγ SUBUNIT DIMER BY
CK2 PHOSPHORYLATED PHOSDUCIN-LIKE PROTEIN AND THE CHAPERONIN
CONTAINING TCP-1

Phosducin-like protein (PhLP) binds G-protein βγ subunits and is thought to assist in
assembly of the Gβγ dimer. Phosphorylation of PhLP at serine residues 18-20 by the
casein kinase 2 (CK2) appears to play an essential role in this process. PhLP has also
been shown to interact with the chaperonin containing TCP-1 (CCT) atop its apical
domain, not entering the substrate folding cavity. However, the physiological role of the
PhLP-CCT interaction in Gβγ dimer formation remains unclear. This study addresses the
mechanism of Gβγ assembly by exploring the specific roles of CCT and CK2
phosphorylation of PhLP in the assembly process. Both overexpressed and endogenous
Gβ were shown to co-immunoprecipitate with CCT to a similar extent as PhLP,
indicating that CCT may be involved in the folding of Gβ. In addition, Gβ
overexpression enhanced the binding of PhLP to CCT, suggesting the formation of a
ternary PhLP-Gβ-CCT complex. In contrast, overexpression of PhLP caused the release
of Gβ from CCT. This release was blocked by a PhLP S18-20A variant that lacks the
S18-20 CK2 phosphorylation site. PhLP S18-20A has been previously shown to
negatively affect Gβγ dimer formation, suggesting a correlation between PhLP-mediated
release of Gβ from CCT and Gβγ assembly. Experiments investigating the role of Gγ in
this process show that Gγ does not interact with CCT nor is it the essential factor in the
release of Gβ from CCT. A new model is therefore proposed for Gβγ assembly

involving the formation of a PhLP-Gβ-CCT ternary complex followed by the release of a
phosphorylated PhLP-Gβ complex from CCT. In the PhLP-Gβ complex, the Gγ binding
face of Gβ is exposed, allowing for the formation of the Gβγ dimer.
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CHAPTER 1
INTRODUCTION TO G-PROTEIN SIGNALING, PHOSDUCIN-LIKE PROTEINS,
AND THE CYTOSOLIC CHAPERONIN CONTAINING TCP-1

In order for cells to respond to their environment, extracellular stimuli must be
able to elicit an intracellular response. Cellular receptors are one method of facilitating
this process. The superfamily of G-protein coupled receptors (GPCRs) comprises
roughly two percent of human genes, contributing substantially to cell signaling and
communication (Ben-Shlomo et al., 2003). Because of their significance and wide range
of functionality, drug development often targets GPCRs and the G-protein pathway,
making it essential to better understand their modes of action.
Although most GPCRs display a high degree of ligand specificity, the fact that
there are a large number of GPCRs within the superfamily permits a wide variety of
ligands to stimulate a G-protein-mediated response. GPCRs contain seven
transmembrane helices whose hydrophobicity allows them to span the plasma membrane
(Ben-Shlomo et al., 2003; Preininger and Hamm, 2004; Sealfon, 2005, Wettschureck and
Offermanns, 2005). Ligand binding and transmembrane regions vary between families,
giving the receptors specificity. However, conserved essential residues among GPCRs
allow them to function similarly in activation of G-proteins (Palczewski et al., 2000).
A model for GPCRs comes from rhodopsin, the abundant, well-characterized,
retinal GPCR (Fig. 1.1). Upon activation, rhodopsin undergoes a conformational change,
moving helix VI in relation to helix III and altering the intracellular face of the GPCR.
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This movement enhances G-protein association with the GPCR resulting in activation of
the G protein (Farrens et al., 1996).

A

B

C

Figure 1-1. GPCR structure and mechanism of activation. Rhodopsin is used as a model for the
structure and mechanism of activation of GPCRs. (A) A 2-dimensional representation of rhodopsin shows
the seven helices of the GPCR spanning the plasma membrane. The N-terminus is located extracellularly
and the C-terminus is found intracellularly. (B) A ribbon diagram models the packing of the GPCR
helicies (Palczewski et al., 2004). (C) Rotation of helix VI (f) in relation to helix III (c) causes a
conformational change that enhances G-protein binding to the intracellular side of the GPCR (Dunham and
Farrens, 1999).
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G-proteins are heterotrimers made up of α, β, and γ subunits that associate with
the intracellular surface of the plasma membrane. Binding to an activated receptor causes
the dissociation of GDP from Gα, allowing GTP to enter in its place in the nucleotide
binding site. GTP binding causes a conformational change in the Gα subunit,
destabilizing its interaction with Gβγ, resulting in the dissociation of Gα-GTP from Gβγ.
Each complex is then free to interact with its respective effectors. Activation of Gproteins allows them to target a variety of effectors, thereby propagating the original
extracellular signal (Cabrera-Vera et al., 2003; Wettschureck and Offermanns, 2005).
The G protein is turned off by the hydrolysis of GTP to GDP on the Gα subunit, making
it available to reassociate with Gβγ and return to the plasma membrane to await
activation once again.
Although Gα contains some intrinsic GTPase activity, the rate at which it
hydrolyzes GTP in vitro is much slower than under physiological conditions, suggesting
that other proteins are involved in accelerating this process in vivo (Cabrera-Vera et al.,
2003; Wettschureck and Offermanns, 2005). One family of proteins, regulators of Gprotein signaling (RGS), were discovered and named accordingly because of their role in
assisting Gα’s hydrolysis of GTP to GDP. RGS proteins act by stabilizing Gα in its
GTPase active conformation. Although they do not directly contribute any catalytic
residues, RGS proteins stabilize the position of a key glutamine residue of Gα which
orients a water molecule required for nucleophilic attack in GTP hydrolysis (Tesmer et
al., 1997). Regulation of RGS proteins and the rate of subsequent GTP hydrolysis
determines the duration of the G protein’s affect on its effectors.
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The 16 human genes encoding Gα subunits can be grouped into four main
families—Gαs, Gαq/11, Gα12/13, and Gαi/o, with each family containing several genes that
target similar effectors. Gαs primarily activates isoforms of adenylyl cylase (AC) while
Gαq/11 stimulates isoforms of phospholipase C-β (PLC-β). Gα12/13 has a large number of
effectors varying from Na+/H+ exchangers to RhoA GTPase activating proteins. Gαi/o
family members also have a variety of effectors with inhibition of AC and activation of
cGMP phosphodiesterase as the principle targets. Because Gαi/o is often found in higher
concentrations, its dissociation from its Gβγ subunits is thought to allow Gβγ to activate
its downstream effectors (Wettschureck and Offermanns, 2005).
Originally, Gβγ was thought to lack its own effectors and only facilitate G-protein
signaling by assisting Gα’s interaction with the plasma membrane and receptors.
However, the existence of five different Gβ subunits and twelve Gγ subunits in the
human genome suggest this first hypothesis is unlikely (Cabrera-Vera et al., 2005;
Wettschureck and Offermanns, 2005). Four of the five Gβ subunits bind Gγ tightly and
these Gβγ complexes have been shown more recently to have a number of effectors. Note
that Gβ5 has less sequence homology than the other four Gβ subunits and binds Gγ
weakly. Although Gβ5 has some in vitro interactions with the Gγ2, it displays greater
affinity for the Gγ-like domain of RGS proteins, suggesting a slightly different
contribution to G-protein signaling (Yoshikawa et al., 2000; Wettschureck and
Offermanns, 2005). The other Gβγ dimers are known to upregulate isoforms of PLC-β
and the β-adrenergic receptor kinase and to downregulate isoforms of AC (Cabrera-Vera
et al., 2003; Wettschureck and Offermanns, 2005). Gβγ also regulates ion-channels,
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activating G-protein-activated inwardly rectifying K+ channels (GIRKs) and inhibiting
voltage-gated Ca2+ channels (Dascal, 2001). As the number of known Gβγ effectors
continues to grow, it becomes increasingly important to understand the regulation of
these subunits.
Two Gβγ binding partners have been described as regulators of Gβγ signaling:
phosducin (Pdc) and phosducin-like protein (PhLP). While Pdc is primarily found in the
retina and pineal gland, PhLP is widely expressed in a variety of tissues. Both Pdc and
PhLP are members of the Pdc gene family, which consists of three subgroups: Pdc-I, PdcII, and Pdc-III. Both Pdc and PhLP are members of the Pdc-I subgroup (Blaauw et al.,
2003), and they both bind Gβγ with high affinity (Savage et al., 2000). PhLP isoforms in
subgroups II and III do not bind Gβγ, and all future references to PhLP will refer to the
member of the Pdc-I family.
PhLP shares a 41% amino acid identity and a 65% homology with Pdc (Miles et
al. 1993). Both Pdc and PhLP’s interactions with the Gβγ were initially thought to be
inhibitory in nature, preventing Gβγ from performing its normal functions (Bauer et
al.,1992; Lee et al., 1992; Schroder and Lohse, 1996; McLaughlin et al., 2002a).
However, disruption of the PhLP gene in the chestnut blight fungus Cryphonectria
parasitica (Kasahara et al., 2000), the soil amoeba Dictyostelium discoideum (Blaauw et

al., 2003), and most recently the fungus Aspergillus nidulans (Seo and Yu, 2006) and the
nematode Caenorhabditis elegans (Lacosta et al., 2006) show physiological phenotypes
very similar to those of Gβ null mutants. These findings indicate that PhLP may act as a
positive rather then a negative regulator of G-protein signaling.
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Another insight into the role of PhLP comes from proteomic analyses to identify
its binding partners. These analyses identified the chaperonin containing TCP-1 (CCT)
as a major PhLP binding partner (McLaughlin et al. 2002b). CCT is a large protein
complex that assists in the folding of nascent polypeptides into their native structures
(Valpuesta et al., 2002). It is similar in many respects to the prokaryotic chaperone
GroEL. CCT is comprised of two rings placed back to back to form a toroid structure.
Each ring contains eight different subunits that are conserved between the two rings.
ATP binding on one side of CCT causes a conformational change allowing for protein
folding in the other side (Llorca et al., 2001). Unlike GroEL, CCT displays substrate
specificity. Actin and tubulin are two of the well known substrates of CCT, but the list
continues to grow as more proteins are shown to require CCT to fold to their native
conformations (Thulasiraman et al., 1999; Siegers et al., 2003). Despite its high affinity
for the chaperonin, PhLP does not require CCT to fold into its native state. Denatured
PhLP spontaneously refolds in the absence of CCT, and native PhLP exhibits a two-fold
increase in binding affinity for CCT over that of denatured PhLP (McLaughlin et al.
2002b).
PhLP-CCT complexes visualized through cryo-electron microscopy (cryo-EM)
indicate that PhLP does not bind in the folding cavity of CCT but rather sits atop CCT’s
apical domains (Martin-Benito et al. 2004, Fig. 1.2). This interaction exhibits some
similarities to the binding of the co-chaperone prefoldin to CCT, though PhLP only binds
one of the two rings in a one-to-one PhLP:CCT stoichiometry, whereas prefoldin binds in
a two-to-one prefoldin:CCT complex (Martin-Benito et al., 2002) There appear to be
two major conformations for the PhLP-CCT interactions with PhLP binding subunits on
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opposite sides of the ring. In 65 % of the complexes, PhLP interacts with CCT subunits
γ/θ on one side and α/ε/ζ on the other side. The other 35 % of the complexes consists of
interactions with δ/η on one side and ζ/β/γ on the other (Martin-Benito et al. 2004).
These apical interactions prevent other proteins from entering the folding site of CCT.
Overexpression of PhLP in CHO cells inhibits CCT-dependent proteins from binding and
folding at normal levels, suggesting a role of PhLP as a regulator of protein folding
(McLaughlin et al. 2002b, Martin-Benito et al. 2004). Combining these structural
observations with the findings from the genetic studies indicating that PhLP is required
for Gβ function leads to the hypothesis that PhLP and CCT may participate in Gβγ
folding and complex assembly.

Figure 1-2. PhLP binds on top of the apical domain of CCT. Computer modeling from CryoEM data
shows PhLP interactions with CCT. (A) Top and (B) side views of show PhLP binding atop CCT and
occluding CCT’s protein folding cavity. (C) CCT in its un-bound state. (D) and (E) show PhLP
interactions with specific subunits of CCT. Conformation (D) was observed to occur 65% of the time, and
conformation (E) the other 35% (Martin-Benito et al., 2004).
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This hypothesis was tested in a recent study measuring the effects of siRNAmediated inhibition of PhLP expression nascent Gβγ dimer assembly (Lukov et al.,
2005). PhLP knockdown in mammalian cells decreased the total Gβ protein present in
the cell without changing the Gβ mRNA level. This result suggested a translational or
post-translational affect of PhLP on Gβ. Further investigation showed that the ability of
Gβ to assemble into dimers with Gγ was impaired upon siRNA-mediated depletion of
PhLP. The rate at which Gβγ assembly occurred was tightly linked to PhLP expression
levels. A 4-fold reduction in PhLP resulted in a five-fold decrease in the rate of Gβγ
assembly, while PhLP overexpression enhanced the rate of assembly by 4-fold (Lukov et
al., 2005).
In attempting to understand what contributes to this phenomenon, PhLP variants
with alanine substitutions at serine residues 18-20 were created. These serine residues
have been shown to be actively phosphorylated by CK2 both in vitro and in vivo and
appear to contribute to PhLP’s regulation of Gβγ (Humrich, et al., 2003; Lukov et al.,
2006). Overexpression of PhLP mutant S18-20A, which cannot be phosphorylated at
those residues, decreases Gβγ expression by 70-80%. Furthermore, PhLP S18-20A
overexpression decreased the rate of Gβγ assembly by 4-fold below the control while
endogenous PhLP overexpression increased the rate of assembly by 4-fold above the
control, a disparity of almost 16-fold between PhLP-WT and PhLP S18-20A (Lukov et
al., 2005). It appears then that CK2 phosphorylation of PhLP at residues 18-20 is
necessary for PhLP-mediated assembly of Gβγ. Note that another study shows that CK2
phosphorylation at these residues appears to have no affect on PhLP binding to Gβγ,
while causing a 7-fold increase in the binding of PhLP to CCT, suggesting that CCT may
8

also participate in this assembly process (Lukov et al., 2006). However, a PhLP variant
which lacks the first 75 N-terminal residues (PhLP ∆1-75) binds Gβ with low affinity but
binds CCT well. This variant was even more effective in inhibiting Gβγ expression and
assembly than the PhLP S18-20A variant. Furthermore, another PhLP variant (PhLP
132-135A) that binds Gβ normally but CCT very poorly shows no negative affect on the
rate of Gβγ assembly compared to PhLP-WT (Lukov et al., 2005).
Clearly the roles of PhLP-CCT and PhLP-Gβγ interactions in Gβγ assembly
remain inconclusive, particularly in relationship to each other. From these studies it
appears that the PhLP-CCT interaction is not necessary for Gβγ assembly while the
PhLP-Gβγ interaction and CK2 phosphorylation of PhLP are essential. In contrast,
another study shows that siRNA-mediated depletion of CCT leads to a decrease in Gβγ
expression, a similar affect to that of the PhLP S18-20A and PhLP ∆1-75 variants
(Humrich et al., 2005; Lukov et al., 2005). The following research reconciles this
disparity and addresses the role of both PhLP and CCT in the Gβγ assembly process by
showing the formation of a ternary PhLP-Gβ-CCT complex. Furthermore, the role of
PhLP phosphorylation in this process is shown to mediate the release of Gβ from CCT
thereby allowing it to interact with Gγ. A new model is therefore proposed for the
assembly of Gβγ through the formation of a ternary PhLP-Gβ-CCT complex.
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CHAPTER 2
EXPERIMENTAL PROCEDURES
Materials – DMEM F-12 50/50 was purchased from Mediatech, Inc.
Lipofectamine PLUS reagent was from Invitrogen. The Coomassie Plus Protein Assay
reagent was from Pierce. ECL Plus Western blotting chemiluminescence reagents and
[35S] Methionine were from Amersham Biosciences. The anti-Gβ1 antibody was
prepared as described (Lukov et al., 2004) and then affinity purified on a peptide affinity
column. The anti-PhLP antibody was also prepared as described previously (Thulin et
al., 1999). Anti-CCT-ε (Serotec), anti-c-myc (BioMol), anti-Flag (Sigma-Aldrich) and
anti-HA (Roche) antibodies were purchased from the commercial sources indicated.
Anti-mouse, anti-rat, and anti-rabbit horseradish peroxidase-conjugated secondary
antibodies were purchased from Calbiochem. Human embryonic kidney (HEK)-293 cells
were obtained from the American Type Cell Culture repository. Midi-prep kits used for
DNA preparation, L-Glutamine, IGEPAL (NP-40), and protease inhibitor cocktail were
all from Sigma Aldrich. PMSF was purchased from Spectrum Chemicals. Fetal bovine
serum was from HyClone. Protein A/G beads used for immunoprecipitation were from
Santa Cruz Biotechnology and PBS was from Fisher.
Cell Culture – HEK-293 cells were grown in DMEM F-12 50/50 supplemented
with 10% fetal bovine serum. Cells were grown at 37oC with 5% CO2 and were
subcultured regularly to maintain viability. Cells were not used beyond 25 passages.
cDNA constructs – Human PhLP and Pdc were cloned into the pcDNA 3.1 B
vector containing c-myc and His6 tags (Invitrogen) as described (Carter et al., 2004;
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Lukov et al., 2005). PhLP variants S18-20A and ∆1-75 were both created using PCR
based methods as described (Lukov, 2005). N-terminal HA-tagged Gγ2 and N-terminal
Flag-tagged Gβ1 cDNA in pcDNA 3.1 were obtained from the UMR cDNA Resource
Center.
CCT Co-immunoprecipitation - HEK-293 cells were split and plated in 6-well
plates, or 100 mm dishes for endogenous Gβ experiments, to be 70-80% confluent the
following day. Cells were then transfected with the indicated cDNAs using
Lipofectamine Plus reagent. After 40-48 hours, the cells were washed with PBS and
solubilized in 200 µl of immunoprecipitation buffer (~2% IGEPAL (NP-40) in PBS) per
well or 1.2 ml per dish. For each ml of this solution, 6 µl of 100 mM PMSF and 4.5 µl of
Sigma protease inhibitor cocktail were added. The cells were passed 10 times through a
25 gauge needle and then centrifuged at 14,000 rpm for 10 minutes. If protein
concentration determinations were necessary, 10 µl of sample was removed and diluted
in 40 µl H20 and analyzed with the Coomassie Plus assay. If the protein concentration
disparity was greater than 10%, samples were adjusted with immunoprecipitation buffer
to equalize the protein concentrations.
CCT was immunoprecipitated by first adding 2.5 µg anti-CCTε per well, 3.5 µg
per 2-wells for endogenous PhLP, or 10 µg per 100 mm dish for endogenous Gβ and
incubated with rotation at 4oC for at least 30 minutes. This was followed by the addition
of 25, 35, or 60 µl of a 50% slurry of protein A/G beads, depending on the amount of
antibody added, followed by a second 30 min incubation. After three washes with
immunoprecipitation buffer, complexes were solubilized in 4X SDS sample loading
buffer. Samples were then boiled for 5 minutes, with the exception of endogenous Gβ
11

samples which were not boiled, and then resolved on 10% Tris-Glycine SDS-PAGE or
16.5% Tris-Tricine SDS-PAGE gels for Gγ detection.
Proteins were transferred to a nitrocellulose membrane and blots were blocked in
5% non-fat dry milk in TBS-T. Anti-HA Gγ blots were blocked in 2% BSA or 2% nonfat dry milk in TBS. Primary antibodies were diluted in blocking buffers and incubated
with rotation overnight and secondary antibodies were diluted in TBS-T or TBS and
incubated for 45-60 minutes with rocking. Between primary and secondary incubations
and before development, the blots were washed three times for 10 minutes with TBS-T or
TBS for Gγ blots. All blot were developed at 4oC. Blots were developed using
chemiluminescent ECL reagents and detected on a Storm860 phosphoimager and
quantified using ImageQuant software (GE Healthcare) or blots were developed using 4chloronaphtol for colorimetric detection, the blot was photographed and digitized with an
Alpha Innotech IS-500 digital imaging system, and the image was quantified using
ImageJ software.
Antibody dilutions for immunoblotting were as follows. For PhLP-myc and Pdcmyc detection, the mouse anti-myc primary antibody was diluted 1:1000 and the goat
anti-mouse horseradish peroxidase-conjugated secondary antibody was diluted 1:2000.
For Flag-Gβ detection, the mouse anti-Flag primary antibody was diluted 1:1000 and the
goat anti-mouse horseradish peroxidase-conjugated secondary antibody was diluted
1:2000. Endogenous PhLP was detected with a 1:5000 dilution of an anti-PhLP antibody
(Thulin et al. 1999) followed by a 1:2000 dilution of goat-anti-rabbit horseradish
peroxidase-conjugated secondary antibody. Endogenous Gβ was detected with a 1:1500
dilution of affinity-purified anti-Gβ antibody (Lukov et al. 2004) incubated overnight and
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then detected with a 1:2000 dilution of goat-anti-rabbit horseradish peroxidaseconjugated secondary antibody. For HA-Gγ2, a 1:500 dilution of rat anti-HA antibody
and a 1:2000 dilution of goat-anti-rat horseradish peroxidase-conjugated secondary
antibody were used.
Radiolabel Pulse-Chase Assay – The rate of release of nascent Gβ from CCT was
measured using a radiolabel pulse-chase assay (Lukov et al., 2005). Six-well plates of
HEK-293 cells were co-transfected with 1.0 µg of Flag Gβ, HA-Gγ or PhLP-myc cDNA
variants as indicated. After a 10 min pulse, the radiolabel was chased for the times
indicated and the cells were harvested in 220 µl of immunoprecipitation buffer. The
extract was divided into two 95 µl samples and 2.5 µl of 1 µg/µl anti-CCTε antibody
(Serotec) was added to one sample and 3.0 µl of 1 µg/µl anti-Flag antibody was added to
the other sample. The immunoprecipitation and analysis of the radiolabeled proteins coimmunoprecipitating with CCT were carried out as described (Lukov et al., 2005). The
Gβ band was clearly separated from the other radiolabeled bands, facilitating its
quantification. The amount of Gβ in the CCT immunoprecipitate was divided by that in
the Flag-Gβ immunoprecipitate to determine the fraction of the total Gβ bound to CCT.
These values were expressed as a percentage of the 30 min time point in order to readily
compare the rates of Gβ dissociation from CCT. The data were fit to a first order
dissociation rate equation using the Kaleidagraph graphics software to determine the
dissociation rate constant k. From the k values, the half-life was calculated by the
equation t1/2 = ln 2/k.
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CHAPTER 3
RESULTS
Gβ binds CCT in a ternary complex with PhLP – There appear to be inconsistencies,
as noted in the introduction, concerning the role of the PhLP-CCT interaction in Gβγ

assembly. The fact that the PhLP ∆1-75 variant with poor Gβγ binding but normal CCT
binding was such a potent inhibitor of Gβγ assembly confirmed the requirement for PhLP
in the formation of the Gβγ dimer (Lukov et al. 2005). In contrast, the lack of effect of
the PhLP 132-135A variant with normal Gβγ binding but poor CCT binding brought into
question the potential role of CCT in the assembly process. Yet the manner in which
PhLP bound CCT above the folding cavity in the cryo-EM structure of the PhLP-CCT
complex suggested that Gβ or Gβγ might sit below PhLP in the folding cavity, forming a
ternary complex with CCT (Martin-Benito et al. 2004). Furthermore, the correlation
between the increase in binding of PhLP to CCT upon phosphorylation of S18-20 and the
necessity of phosphorylation of S18-20 for full activity in Gβγ assembly suggested that
the effects of PhLP phosphorylation on assembly may occur through CCT. These
apparently conflicting results led to further investigation of the potential role of CCT in
Gβγ assembly.
If CCT does participate in the assembly process, then it must interact with Gβ or
Gγ or both. An interaction between Gβ and CCT has been observed in yeast protein
interaction screens, but no such interaction has been reported in mammalian cells.
Therefore, the binding of Gβ and Gγ to CCT was assessed by co-immunoprecipitation of
over-expressed Gβ or Gγ in HEK-293 cells.
14

Gβ co-immunoprecipitated with CCT

robustly, to a similar extent as over-expressed PhLP, whereas over-expressed Pdc, which
does not bind CCT, was not found in the CCT immunoprecipitate (Figure 3-1). Thus, Gβ
appears to be specifically interacting with CCT under over-expression conditions. In
contrast, over-expressed Gγ did not co-immunoprecipitate with CCT (Figure 3-1). To
determine whether the interaction also occurred with endogenous amounts of Gβ, the
experiment was also done without over-expressing Gβ. Co-immunoprecipitation of Gβ
with CCT was also observed with endogenous Gβ, confirming the results of the overexpression experiments (Figure 3-2).
The manner in which PhLP binds CCT at the top of the apical domains without
entering the folding cavity (Martin-Benito et al., 2004) suggests that PhLP, Gβ and CCT
might form a ternary complex in the process of Gβγ folding. If such a ternary complex
does exist, then PhLP would be predicted to increase the binding of Gβ to CCT and vice
versa. To test this possibility, the effects of PhLP or Gβ over-expression on the binding
of the other to CCT was measured. As predicted, Gβ over-expression increased the
binding of endogenous PhLP to CCT (Figure 3-3). However, PhLP over-expression
unexpectedly caused a small but reproducible decrease in Gβ binding to CCT (Figure 32).
Gβ1

PhLP

Pdc

Gγ2

CCT IP
Lysate

Figure 3-1. Gβ
β binds CCT. HEK-293 cells were transfected with Flag-Gβ1, PhLP, Pdc or HA-Gγ2 and
cell extracts were immunoprecipitated with an antibody to CCTε to bring down CCT complexes. The
immunoprecipitates were immunoblotted for Gβ1, PhLP, Pdc or Gγ2.
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Figure 3-2. CK2
phosphorylated PhLP
mediates the release of
Gβ
β from CCT. The effects
of PhLP on Gβ binding to
CCT measured by coimmunoprecipitation. HEK293 cells were transfected
with wild-type PhLP, the
PhLP 218-20A or ∆1-75
variants, or empty vector.
Cell extracts were
immunoprecipitated with the
anti-CCTε antibody and
immunoblotted for
endogenous Gβ1. A
representative immunoblot is
shown. Bars in the graph
represent the average ± s.e. of
the Gβ band intensity relative
to the empy vector control
from 4 separate experiments.
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Figure 3-3. Gβ
β enhances
the binding of PhLP to
CCT. The effects of Gβ on
the binding of endogenously
expressed PhLP to CCT
measured by coimmunoprecipitation. HEK293 cells were transfected
with Gβ1, CCT was
immunoprecipitated as in
Figure 3-2, and samples were
immunoblotted for
endogenous PhLP. A
representative immunoblot is
shown. Bars in the graph
represent the average ± s.e. of
the PhLP band intensity
relative to the empty vector
control from 3 separate
experiments.

It is possible that this decrease in Gβ binding to CCT might be caused by PhLP
catalyzed Gβγ assembly and release of the Gβγ dimer from CCT. To test this possibility,
the effects of two PhLP variants that do not support Gβγ assembly on Gβ binding to CCT
were also tested. One variant was PhLP S18-20A and the other was a truncation variant
in which residues 1-75 had been removed (PhLP ∆1-75) (Lukov et al., 2005). Both of
these variants bind CCT, but they block Gβγ assembly in a dominant negative manner
(Lukov et al., 2005). Over-expression of either of these variants increased endogenous
Gβ binding to CCT dramatically (Figure 3-2). Thus, it appears that in the absence of
S18-20 phosphorylation, PhLP forms a ternary complex with Gβ and CCT that cannot
progress in the assembly process. It is interesting to note that the PhLP∆1-75 variant
binds Gβγ very poorly (Lukov et al., 2005), yet it is still able to stabilize the complex
between Gβ and CCT. This observation indicates that PhLP ∆1-75 may do so more
through interactions with CCT than through interactions with Gβ.
PhLP phosphorylation is required for the release of Gβ from CCT and interaction
with Gγ - To further investigate the apparent correlation between the destabilization of
the PhLP-Gβ-CCT ternary complex by PhLP phosphorylation and the requirement for
PhLP phosphorylation in Gβγ assembly, the effects of Gγ on ternary complex formation
with several PhLP variants was measured. Gβ was over-expressed in HEK-293 cells
with Gγ and PhLP variants as indicated, and the amount of Gβ co-immunoprecipitating
with CCT was measured (Figure 3-4). Co-expression of Gγ caused a decrease in Gβ
binding to CCT that was intensified by the co-expression of wild-type PhLP. In striking
contrast, Gβ binding to CCT was greatly enhanced by co-expression of PhLP ∆1-75 and
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was completely insensitive to co-expression of Gγ. Co-expression of PhLP S18-20A also
enhanced Gβ binding to CCT significantly, and Gγ had much less of an effect on binding
than with wild-type PhLP. Interestingly, the effects of PhLP ∆1-75 and S18-20A on Gβ
binding to CCT in the presence of Gγ were quantitatively very similar to their effects on
Gβγ assembly. PhLP ∆1-75 completely blocked Gβγ assembly (Lukov et al., 2005) and
Gγ-mediated dissociation of Gβ from CCT, while PhLP S18-20A decreased the rate of
Gβγ assembly by 15-fold (Lukov et al., 2005) and Gγ-induced dissociation of Gβ from
CCT by 9-fold (compare the Gβγ PhLP-WT sample to the Gβγ PhLP S18-20A sample in
Figure 3-4). From these data, it appears that PhLP phosphorylation contributes to Gβγ
assembly by enhancing the ability of Gγ to release Gβ from the ternary complex.
8

7

Gβ bound to CCT
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3
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1

0

Gβ

Gβγ

Gβ
Gβγ
Gβ
PhLP-W T PhLP-W T S18-20A

Gβγ
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Gβ
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Gβγ
∆1-75

CCT IP
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Figure 3-4. The effects of PhLP phosphorylation and Gγγ co-expression on Gβ
β binding to CCT. HEK293 cells were transfected with Flag-Gβ1, HA-Gγ2 and the PhLP variants as indicated. Cell extracts were
immunoprecipitated with an antibody to CCTε and then immunoblotted for Gβ. A representative
immunoblot is shown. Bars in the graph represent the average ± s.e. of the Gβ band intensity relative to the
Gβ PhLP-WT band from 3 separate experiments.
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There are two possible mechanisms by which phosphorylated PhLP could
contribute to Gγ-mediated release of Gβ from CCT. Both involve a conformational
change in the ternary complex upon PhLP phosphorylation. First, PhLP phosphorylation
could induce a conformation that allows Gγ to access Gβ in the ternary complex and form
the Gβγ dimer. The Gβγ would then be released from CCT. Second, phosphorylation
could induce a conformation that releases PhLP-Gβ from CCT, thereby freeing the Gγ
binding site on Gβ for Gβγ association to occur. To distinguish between these two
mechanisms, the effects of Gγ and PhLP over-expression on the rate of dissociation of
Gβ from CCT were measured. In this experiment, cells co-expressing Gβ with Gγ, PhLP
or PhLP S18-20A were pulsed with

35

S-methionine for 10 minutes to label the nascent

polypeptides and then were chased with unlabeled methionine. At the times indicated,
the cells were lysed and CCT was immunoprecipitated. The co-immunoprecipitating
proteins were separated by SDS-PAGE and the amount of [35S] in the Gβ band was
quantified. In the absence of PhLP or Gγ co-expression, the dissociation rate of nascent
Gβ from CCT was very slow, with a t1/2 of ~ 8 hrs. PhLP co-expression increased the
rate by 4-fold to a t1/2 of ~ 2 hrs. In contrast, PhLP S18-20A co-expression did not
increase the dissociation rate (Figure 3-5A). When Gγ was co-expressed with Gβ, the
dissociation rate increased by more than 2-fold to a t1/2 of ~ 3 hrs, while when both Gγ
and PhLP were co-expressed, the t1/2 increased even further to ~ 2 hrs, the same value
observed in the absence of Gγ over-expression (Figure 3-5B). When PhLP S18-20A was
co-expressed with Gγ, there was essentially no Gβ dissociation, similar to what was seen
in the absence of Gγ over-expression (Figure 3-5B). These effects of Gγ, PhLP and PhLP
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S18-20A on the dissociation rates are consistent with their effect on the steady-state
binding of Gβ to CCT (Figure 3-4) and further demonstrate that PhLP phosphorylation is
required for the release of Gβ from the ternary complex. These findings are able to
distinguish between the two potential mechanisms proposed above. The enhanced rate of
dissociation of Gβ from CCT upon PhLP over-expression in the absence of Gγ overexpression (Figure 3-5A) is consistent with the second mechanism in which a
phosphorylated PhLP-Gβ complex would be released prior to Gγ binding to Gβ.

A

Transfection conditions
Gβ
β

B

Gβ
β Dissociation rate
7.5 ± 2.5

Transfection conditions

Gβ
β, PhLP S18-20A

8.8 ± 2.3

Gβ
β, Gγγ
Gβ
β, Gγγ, PhLP S18-20A

Gβ
β, PhLP WT

2.2 ± 0.4

Gβ
β, Gγγ, PhLP WT

Gβ
β Dissociation rate
3.3 ± 0.5
41 ± 31
2.3 ± 0.5

Figure 3-5. The effects of PhLP phosphorylation and Gγγ on the rate of Gβ
β release from CCT. (A)
HEK-293 cells were transfected with Flag-Gβ1 and the indicated PhLP variants. The pulse-chase assay was
performed with times indicating the sum of the 10 min pulse and the variable chase periods. After the
chase times indicated, cell extracts were immunoprecipitated with antibodies to CCTε or Gβ1. Proteins
were resolved by SDS-PAGE and radiolabeled bands were detected using a phosphorimager. The Gβ band
intensities were quantified, and ratios of nascent Gβ1 in the CCT immunoprecipitate versus the total nascent
Gβ in the Gβ immunoprecipitate were calculated and plotted as a percentage of the ratio at the first time
point. Lines represent a fit of the data from 3 separate experiments to a first-order rate equation. Values for
t1/2 are shown below the graph. (B) The effects of Gγ on PhLP-mediated release of nascent Gβ1 from CCT
were measured as in panel A in HEK-293 cells co-expressing HA-Gγ2 in addition to Flag-Gβ1 and PhLP.
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This result would not be expected in the first mechanism in which Gγ binding would be
required for release of Gβ from CCT. Similarly, the observed lack of increase in the Gβ
dissociation rate upon co-expression of Gγ with PhLP would be predicted by the second
mechanism but not by the first. On the other hand, the increased release of Gβ from CCT
upon Gγ over-expression in the absence of PhLP over-expression is consistent with the
first mechanism, but this result could also be explained by the second mechanism if the
endogenous PhLP were acting catalytically to release Gβ from CCT for association with
Gγ. In this case, the dissociation process would be drawn forward by the formation of the
Gβγ dimer and its association with Gα and cell membranes (see Figure 3-7).
To further assess the role of Gγ in the release of Gβ from CCT, the possible
association of Gγ with Gβ and PhLP in CCT complexes was determined. Gγ was coexpressed with the indicated combinations of Gβ and the PhLP variants, the CCT
complexes were immunoprecipitated and the samples were immunoblotted for Gγ. Gγ
was not found in any of the CCT immunoprecipitates (Figure 3-6), despite the fact that
Gβ and PhLP could be readily found under these conditions (see Figures 3-1 – 3-3).

Std

Gγ, Gβ,
PhLP ∆1-75

Gγ, Gβ,
PhLP S18-20A

Gγ, Gβ,
PhLP WT

Gγ, Gβ

Gγ

PhLP.

Gγ, PhLP WT

Thus, it appears that Gγ does not interact with CCT in any of its complexes with Gβ and

Gγ

CCT IP

Lysate

Gγ

Figure 3-6. Assessment of Gγγ binding to CCT. HEK-293 cells were transfected with Flag-Gβ1, HA-Gγ2,
or PhLP variants as indicated. Cells extracts were immunoprecipitated with an antibody to CCTε and then
immunoblotted for Gγ. A representative blot is shown. The Std lane in the CCT IP was lysate from the Gγ
transfected cells.
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Together, the data in Figures 3-4 thru 3-6 indicate that PhLP phosphorylation
results in the release of a PhLP-Gβ complex from CCT that can then associate with Gγ to
form the Gβγ dimer. This conclusion is also supported by the previously reported
observation that PhLP forms a stable complex with Gβ that does not include Gγ (Lukov
et al., 2005).
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Figure 3-7. CK2 phosphorylation-dependent release model of Gβγ
βγ assembly. A model is proposed in
which nascent Gβ forms a ternary complex with CCT and PhLP. If PhLP is not phosphorylated, the
ternary complex is stable and PhLP-Gβ is not released from CCT. If PhLP is phosphorylated, the ternary
complex is destabilized, possibly by electrostatic repulsion between the phosphates in the S18-20
phosphorylation site and negatively charged residues on the CCTα or ε apical domains. Once released, the
PhLP-Gβ complex binds Gγ, forming the Gβγ dimer. The dimer then associates with Gα and membranes
in a manner yet to be defined. In the process, PhLP is released to catalyze another round of dimer
formation. The approximate position of the S18-20 phosphorylation site is depicted by a red oval marked
(P). The relative amount of positive and negative charge on the CCT apical domains that contact the PhLP
N-terminal domain is also indicated. See text for details.
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CHAPTER 4
DISCUSSION
A model for Gβγ assembly – Recent studies have shown that PhLP acts as an
essential chaperone in the assembly of Gβγ dimers by binding the Gβ subunit and thereby
allowing Gγ to associate with Gβ (Lukov et al., 2005; Humrich et al., 2005).
Phosphorylation of PhLP at S18-20 by CK2 was required for Gβγ assembly to occur, yet
the means by which S18-20 phosphorylation contributes to assembly was unknown.
Moreover, CCT had been implicated in the assembly process, but the results were
conflicting (Martin-Benito et al., 2004; Lukov et al., 2005; Humrich et al., 2005). The
current study provides evidence for a molecular mechanism describing both the role of
CCT and PhLP phosphorylation in Gβγ assembly (Figure 3-7). There are five important
steps in this mechanism: 1) the nascent Gβ polypeptide binds CCT. This is a stable
complex that releases Gβ very slowly in the absence of PhLP. 2) PhLP binds forming a
ternary complex. If PhLP is not phosphorylated, then the ternary complex forms in a
stable conformation that does not release PhLP-Gβ and the Gβγ assembly process is
blocked. However, if PhLP is phosphorylated within the S18-20 sequence, then the
ternary complex assembles in a conformation that readily releases the PhLP-Gβ dimer. 3)
PhLP-Gβ dissociates from CCT. The structure of the Pdc-Gtβγ complex shows that Pdc
binds Gβ on the opposite face as Gγ (Gaudet et al., 2006), predicting that the Gγ binding
site on Gβ would be free in the PhLP-Gβ dimer. 4) Gγ binds Gβ forming a PhLP-Gβγ
complex. This complex is stable with a 100 nM binding affinity (Savage et al., 2000).
However, both the Gα binding site and the membrane association surface of Gβγ overlap
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extensively with the PhLP binding site (Savage et al., 2000). Gα and PhLP share similar
binding affinities for Gβγ. However, significantly more Gα is present in the cell, and
there is an abundance of membrane surface on the endoplasmic reticulum and Golgi for
Gβγ binding. Therefore, in the cell PhLP would be expected to be released from Gβγ. 5)
Gβγ associates with Gα and/or the endoplasmic reticulum membrane and is transported
to the plasma membrane (Michaelson et al., 2002). PhLP is then free to catalyze another
round of Gβγ assembly.
This model readily explains the dominant negative effect of the PhLP S18-20A
and PhLP ∆1-75 variants. These variants form PhLP-Gβ-CCT ternary complexes that do
not release PhLP-Gβ for Gγ binding. Such stable ternary complexes would also block the
endogenous, phosphorylated PhLP from forming competent ternary complexes capable of
releasing PhLP-Gβ for Gγ binding. Previous explanations of the dominant negative
effect of PhLP S18-20A which postulated that unphosphorylated PhLP would block Gβ
and Gγ association with CCT (Humrich et al., 2005) or that unphosphorylated PhLP
would form a PhLP-Gβ complex that would not accept Gγ (Lukov et al., 2005) are
incomplete.
Phosphorylation-induced conformational changes – Although CK2
phosphorylation increases PhLP’s binding to CCT in the absence of Gβ (Lukov et al.,
2006), PhLP phosphorylation was necessary for the release of PhLP-Gβ from CCT in the
presence of Gβ (Figures. 3-4,5). The difference between these observations may stem
from differences in the structures of the PhLP-CCT and PhLP-Gβ-CCT complexes. Clues
regarding the nature of the phosphorylation-dependent changes in these structures may be
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gleaned from the cryo-EM studies of the unphosphorylated PhLP-CCT complex (MartinBenito et al., 2004). In this complex, PhLP was shown to interact in two distinct
conformations at the top of the CCT toroid, contacting only the CCT apical domains
(Martin-Benito et al., 2004). In one conformation, the N-terminal phosphorylation site of
PhLP was in close proximity to the CCTα and ε apical domains and in the other
conformation the phosphorylation site was in close proximity to the CCTζ and β apical
domains. The binding surfaces of all eight apical domains are dominated by charged and
polar residues (Pappenberger et al., 2002) with the CCTα and ε binding surfaces having a
high distribution of negative charge, while the CCTζ binding surface exhibits an
extensive positively charged patch.
The S18-20 phosphorylation site of PhLP is harbored within a sequence
(S18SSDEDESD) that is already very negatively charged. The addition of phosphates
within this sequence would create an extremely high concentration of negative charge
that would interact effectively with the positively charged patch of CCTζ. In the
absence of Gβ, phosphorylation could favor the conformation that brings the PhLP
phosphorylation site in close proximity to the CCTζ apical domain, increasing the
binding of PhLP to CCT. In the presence of Gβ, it is possible that interactions with Gβ
may limit the ability of PhLP to rotate on the top of the CCT toroid. Thus, the
phosphorylation site may be fixed in close proximity to the CCTα and ε apical domains,
causing electrostatic repulsion between the negative charges on the CCTα and ε binding
surfaces and the PhLP phosphorylation site. This repulsion might destabilize the ternary
complex and allow the release of the PhLP-Gβ complex. Further studies will be required
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to test the validity of this structural model. It is not clear from the current data whether
phosphorylation occurs prior to or after association of PhLP with CCT (Figure 3-7).
These investigations into the mechanism of PhLP-mediated Gβγ assembly and its
regulation by CK2 phosphorylation suggest that PhLP’s interactions with Gβ and CCT
could be targeted by therapeutics to control the levels of Gβγ expression and thus the
degree of G protein signaling within the cell, perhaps providing additional tools to treat
the myriad of G protein-linked diseases such as heart disease, developmental,
immunological, gastrointestinal and psychological disorders, addictions, and certain
forms of cancer (Wettschureck and Offermanns 2005).
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